Melanoma
This month’s MabDesign market analysis gives you an overview of market dynamics and development projects targeting melanoma treatment.
Persea – new member
Persea is a French biotech developing a game-changing cell and gene therapy for liver cancer.
Sourcin – new international member
Transform procedures into textless multimedia.
Leanbio – new member
Leanbio is a leading Biopharmaceutical CDMO offering end-to-end services in the field of recombinant proteins, mRNA and pDNA.
Nova Biomedical – new member
Nova Biomedical is a world leader in the field of in vitro diagnostics (IVD), distinguished by its international scope and over 40 years of expertise in the development, manufacture and marketing of whole blood analyzers and readers.
GEG Tech – new member
GEG Tech’s mission is to design safe and powerful innovations deriving from genetic engineering.
Blue Bees Therapeutics – new member
Blue Bees Therapeutics is a biotechnology company founded in 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancer, based on a disruptive technology (i.Ther) discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis at CEA Paris-Saclay.
Igyxos Biotherapeutics – new member
Igyxos Biotherapeutics, a French biotechnology company, is dedicated to addressing the growing global need for improved infertility solutions through novel therapeutics that make treatment more effective and efficient for men and women.
Pipebio – new international member
PipeBio is an integrated cloud platform for no-code, end-to-end bioinformatic workflows for therapeutic antibody and biologics discovery.
Takis – new international member
Takis, a biotechnology company based in Rome, Italy, has over 10 years of experience in drug discovery.
Ardena – new international member
Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials.
